SCHEMBL4953284

SCHEMBL4953284

CSCC(OC(=O)C(C)O)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.39
LAP3 P28838 2/20 0.32
RNPEP Q9H4A4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4954299 0.84 RNPEP (0.31) RNPEP
SCHEMBL4949335 0.83 RNPEP (0.44) TP53RNPEP
SCHEMBL4951876 0.83 TP53 (0.34) TP53
SCHEMBL4955410 0.80 METAP2 (0.40) TP53
SCHEMBL3218126 0.79 ENPEP (0.35) RNPEP
SCHEMBL6472491 0.79 ENPEP (0.35) RNPEP
SCHEMBL3218131 0.79 ENPEP (0.35) RNPEP
SCHEMBL5329279 0.78 RNPEP (0.31) RNPEP
SCHEMBL7397297 0.78 ENPEP (0.34) RNPEP
SCHEMBL7397575 0.78 ENPEP (0.34) RNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465471-B2 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2008-12-16 US disclosed
WO-2007147155-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-21 WO disclosed
US-20070292485-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-20 US disclosed
US-20050215623-A1 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2005-09-29 US disclosed
US-20040175434-A1 Antimicrobial compositions NOVUS INTERNATIONAL, INC. 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070292485-A1 POLYOL ESTER COMPOUNDS PNLIP, ELOVL1, ELOVL5 TP53 2697/4885LAP3 2253/4885RNPEP 3086/4885
US-20050215623-A1 Palatability of aquaculture feed TAS2R3, TAS2R1, TAS2R20 TP53 3725/4885LAP3 2388/4885RNPEP 1217/4885
US-20040175434-A1 Antimicrobial compositions MRPL21, FPR1, ARG1 TP53 4079/4885LAP3 3486/4885RNPEP 2140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.